VVN-539

N/A

Report date: 2025/05/30 11:45:48
NME

Base Information

Drug NameVVN-539
Drug Alias NameVVN-539
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 1 inhibitorsRho-associated protein kinase 2 inhibitors
TargetsRho-associated protein kinase 1Rho-associated protein kinase 2
Therapy Area/IndicationsGlaucoma, Open-Angle
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVivaVision Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesVivaVision Biotech Inc
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-Angle
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A